Upgrade to SI Premium - Free Trial

Viridian Therapeutic (VRDN) PT Raised to $34 at RBC Capital

May 6, 2026 4:20 AM
RBC Capital analyst Lisa Walter raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $34.00 (from $30.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change